Patent · US Active

Nuclease inhibitors and methods for their use

US8962001B2 · kind B2 · utility

2Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2013
Grant dateFeb 24, 2015
Priority date
Expiry dateJun 10, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/99
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A class of anionic oligomers and polymers that function for inhibition of nucleases, particularly RNase. Specific inhibitors include mixtures of oligomers of vinyl sulfate. Methods for inhibition or inactivation of one or more nucleases in vitro which comprises the step of contacting the one or more nucleases in a biological medium with one or more of the anionic oligomeric or polymeric inhibitors of this invention. Kits for carrying out a biological procedure, biological reaction and/or a biological assay containing one or more inhibitors of this invention. The use of oligomers and/or polymers of this invention as additives in buffers or reagents. The inhibitors of the invention can also be attached to surfaces to provide for removal of nucleases from media, solutions or other liquids in contact with the solid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.